Swedish Orphan Biovitrum
292,2
SEK
+4,66 %
Mindre end 1K følgere
SOBI
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
Investor consensus
+4,66%
+0,14%
-13,65%
-7,94%
-15,3%
+3,99%
+47,57%
+59,08%
+512,34%
Swedish Orphan Biovitrum operates in the pharmaceutical industry and focuses on the development and distribution of medicines for rare diseases. The company's products are aimed at healthcare institutions and patients with specific medical needs. The business is global with a main presence in Europe, North America and Asia. Swedish Orphan Biovitrum was founded in 1939 and is headquartered in Stockholm, Sweden.
Læs mereMarkedsværdi
104,02 mia. SEK
Aktieomsætning
140,84 mio. SEK
Omsætning
26,03 mia.
EBIT %
21,61 %
P/E
25,7
Udbytteafkast, %
-
Finanskalender
29.4
2025
Delårsrapport Q1'25
8.5
2025
Generalforsamling '25
15.7
2025
Delårsrapport Q2'25
Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ)
Swedish Orphan Biovitrum AB: Sobi publishes Annual and sustainability report for 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools